Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement

In patients with advanced non-small cell lung cancer (NSCLC), comprehensive genetic diagnostics is currently carried out in order to qualify for molecularly targeted therapies and immunotherapy. The aim of the study was to assess the usefulness of the reverse transcriptase (RT-PCR) method in the dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Krawczyk, Paweł, Grenda, Anna, Terlecka, Paulina, Błach, Justyna, Wojas-Krawczyk, Kamila, Kucharczyk, Tomasz, Chmielewska, Izabela, Kieszko, Robert, Jarosz, Bożena, Gil, Michał, Reszka, Katarzyna, Milanowski, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536721/
https://www.ncbi.nlm.nih.gov/pubmed/34686712
http://dx.doi.org/10.1038/s41598-021-00309-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536721/
https://www.ncbi.nlm.nih.gov/pubmed/34686712
http://dx.doi.org/10.1038/s41598-021-00309-3

Ejemplares similares